Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Renal Failure

Free Subscription Articles published in Curr Opin Nephrol Hypertens Retrieve available abstracts of 45 articles: HTML format

Single Articles

October 2025
1. YE WWQ, Malavade T, Bargman JM, Chan CT, et al
   Bringing medical education "home": the university health network and St. Michael's hospital home dialysis fellowship.
   Curr Opin Nephrol Hypertens. 2025 Oct 6. doi: 10.1097/MNH.0000000000001122.
   PubMed     Abstract available
   
   
   September 2025
2. MERLINO L, Tollitt J, Dunne RA, Kalra PA, et al
   Pathophysiology of cognitive impairment in chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 Sep 15. doi: 10.1097/MNH.0000000000001117.
   PubMed     Abstract available
   
   
   July 2025
3. LIARAKOS AL, Randhay A, Wilmot EG
   Continuous glucose monitoring and automated insulin delivery systems in the management of diabetes among individuals with chronic kidney disease on dialysis.
   Curr Opin Nephrol Hypertens. 2025 Jul 15. doi: 10.1097/MNH.0000000000001106.
   PubMed     Abstract available
   
   
   
4. SKOBERNE A
   The impact of conflicts on patients with chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 Jul 15. doi: 10.1097/MNH.0000000000001107.
   PubMed     Abstract available
   
   
   May 2025
5. KHAIRALLAH P
   Agents to treat osteoporosis in chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001091.
   PubMed     Abstract available
   
   
   
6. DELANAYE P, Gama RM, Stehle T
   Impact of the choice of biomarkers and equations to estimate kidney function on the epidemiology of chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001085.
   PubMed     Abstract available
   
   
   
7. POTHULA VENKATA V, Scialla JJ
   Momentum toward patient outcome trials in chronic kidney disease-mineral bone disorder.
   Curr Opin Nephrol Hypertens. 2025 May 19. doi: 10.1097/MNH.0000000000001087.
   PubMed     Abstract available
   
   
   
8. ABU KAR S, Harris RC
   Chronic kidney disease and sex dimorphism.
   Curr Opin Nephrol Hypertens. 2025 May 15. doi: 10.1097/MNH.0000000000001093.
   PubMed     Abstract available
   
   
   
9. THEODORAKOPOULOU MP, Iatridi F, Sarafidis PA
   Aldosterone synthase inhibition in chronic kidney disease.
   Curr Opin Nephrol Hypertens. 2025 May 2. doi: 10.1097/MNH.0000000000001089.
   PubMed     Abstract available
   
   
   
10. FREIRE-FILHO WA, Dalboni MA, Elias RM
    Effects of aging on chronic kidney disease mineral and bone disorder.
    Curr Opin Nephrol Hypertens. 2025 May 2. doi: 10.1097/MNH.0000000000001084.
    PubMed     Abstract available
    
    
    April 2025
11. MARTINEZ-ROJAS MA, Bobadilla NA
    Sodium-glucose cotransporter 2 inhibitors: a novel approach to prevent the transition from acute kidney injury to chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Apr 23. doi: 10.1097/MNH.0000000000001080.
    PubMed     Abstract available
    
    
    
12. SPENCER S, Bhandari S
    Optimizing renin-angiotensin-aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks.
    Curr Opin Nephrol Hypertens. 2025 Apr 8. doi: 10.1097/MNH.0000000000001076.
    PubMed     Abstract available
    
    
    
13. DUQUE EJ, Giachelli C, Moyses RMA
    The role of osteopontin in chronic kidney disease-mineral bone disorder.
    Curr Opin Nephrol Hypertens. 2025 Apr 2. doi: 10.1097/MNH.0000000000001074.
    PubMed     Abstract available
    
    
    March 2025
14. GOLDFARB DS
    The hemodialysis unit: the place where everybody knows your name.
    Curr Opin Nephrol Hypertens. 2025;34:129-130.
    PubMed    
    
    
    February 2025
15. LEDUC C, Tomisawa N, Ronco C, Kalantar-Zadeh K, et al
    The history and future of online hemodiafiltration and online solutions in North America.
    Curr Opin Nephrol Hypertens. 2025 Feb 19. doi: 10.1097/MNH.0000000000001051.
    PubMed     Abstract available
    
    
    January 2025
16. RHEE CM, Kovesdy CP, Unruh M, Crowley S, et al
    Incremental hemodialysis transition in veterans and nonveterans with kidney failure.
    Curr Opin Nephrol Hypertens. 2025;34:33-40.
    PubMed     Abstract available
    
    
    
17. TANTISATTAMO E, Hanna RM, Kalantar-Zadeh K
    Implementing novel diagnostic and therapeutic strategies to improve population health outcomes and equity in kidney disease, dialysis therapies, and transplantation.
    Curr Opin Nephrol Hypertens. 2025;34:1-3.
    PubMed    
    
    
    
18. YERRAM P, Edwards D, Norris KC, Molony D, et al
    Practicing health equity in kidney care by establishing improved access to timely disease management and kidney replacement therapy options: from providers to patients.
    Curr Opin Nephrol Hypertens. 2025;34:48-54.
    PubMed     Abstract available
    
    
    
19. SEGHERS F, Tintillier M, Morelle J
    Recent advances in the understanding of the peritoneal membrane.
    Curr Opin Nephrol Hypertens. 2025;34:77-84.
    PubMed     Abstract available
    
    
    
20. SHAH AD
    Bringing the end-stage kidney disease life plan home.
    Curr Opin Nephrol Hypertens. 2025;34:67-68.
    PubMed    
    
    
    
21. NARASAKI Y, Rhee CM, Kalantar-Zadeh K, Rastegar M, et al
    Why protein-energy wasting leads to faster progression of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025;34:55-66.
    PubMed     Abstract available
    
    
    
22. BROWN CO, Pham PC, Shah A, Dukkipati R, et al
    Population health strategies for health equity in chronic kidney disease management.
    Curr Opin Nephrol Hypertens. 2025;34:41-47.
    PubMed     Abstract available
    
    
    December 2024
23. MARTIN D, Brewster P, Crowley ST
    Preparing for stormy weather: building VA health system resilience for dialysis emergency preparedness in the era of climate change.
    Curr Opin Nephrol Hypertens. 2024 Dec 18. doi: 10.1097/MNH.0000000000001054.
    PubMed     Abstract available
    
    
    
24. WATNICK S
    Use of water in dialysis and its impact on the environment.
    Curr Opin Nephrol Hypertens. 2024 Dec 18. doi: 10.1097/MNH.0000000000001058.
    PubMed     Abstract available
    
    
    
25. WALLACH JD, Medaura JA, Stern L
    Home dialysis: there's no place like home.
    Curr Opin Nephrol Hypertens. 2024 Dec 16. doi: 10.1097/MNH.0000000000001056.
    PubMed     Abstract available
    
    
    
26. 
    Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction.
    Curr Opin Nephrol Hypertens. 2024 Dec 10. doi: 10.1097/MNH.0000000000001055.
    PubMed    
    
    
    November 2024
27. KIM B, Kanchi R, Titus AR, Grams ME, et al
    Built environment and chronic kidney disease: current state and future directions.
    Curr Opin Nephrol Hypertens. 2024 Nov 22. doi: 10.1097/MNH.0000000000001048.
    PubMed     Abstract available
    
    
    
28. BROWN CO, Pham PC, Shah A, Dukkipati R, et al
    Population health strategies for health equity in chronic kidney disease management.
    Curr Opin Nephrol Hypertens. 2024 Nov 21. doi: 10.1097/MNH.0000000000001044.
    PubMed     Abstract available
    
    
    
29. SHRINGI S, Shah AD
    The cardiovascular unphysiology of thrice weekly hemodialysis.
    Curr Opin Nephrol Hypertens. 2024 Nov 6. doi: 10.1097/MNH.0000000000001037.
    PubMed     Abstract available
    
    
    
30. PECCE A, Belhumeur L, Nadeau-Fredette AC
    Staying home when peritoneal dialysis ends: the integrated home dialysis approach.
    Curr Opin Nephrol Hypertens. 2024 Nov 4. doi: 10.1097/MNH.0000000000001034.
    PubMed     Abstract available
    
    
    October 2024
31. SHAMY OE, Sloand JA
    Automation and innovation in home hemodialysis machines.
    Curr Opin Nephrol Hypertens. 2024 Oct 30. doi: 10.1097/MNH.0000000000001033.
    PubMed     Abstract available
    
    
    
32. AL SAHLAWI M, Chan CT, Perl J
    Infection prevention in home dialysis.
    Curr Opin Nephrol Hypertens. 2024 Oct 15. doi: 10.1097/MNH.0000000000001032.
    PubMed     Abstract available
    
    
    
33. QUINN RR, Oliver MJ
    Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes.
    Curr Opin Nephrol Hypertens. 2024 Oct 7. doi: 10.1097/MNH.0000000000001031.
    PubMed     Abstract available
    
    
    September 2024
34. IYENGAR A, Kalyesubula R, Darwish R, Luyckx VA, et al
    International equity in access to home dialysis.
    Curr Opin Nephrol Hypertens. 2024 Sep 13. doi: 10.1097/MNH.0000000000001027.
    PubMed     Abstract available
    
    
    August 2024
35. VAN MIL D, Kieneker LM, Heerspink HJL, Gansevoort RT, et al
    Screening for chronic kidney disease: change of perspective and novel developments.
    Curr Opin Nephrol Hypertens. 2024 Aug 14. doi: 10.1097/MNH.0000000000001016.
    PubMed     Abstract available
    
    
    
36. PEPIN M, Levassort H, Massy ZA
    The impact of chronic kidney disease on cognitive function.
    Curr Opin Nephrol Hypertens. 2024 Aug 13. doi: 10.1097/MNH.0000000000001017.
    PubMed     Abstract available
    
    
    July 2024
37. FRASER SDS, Phillips T
    Quality of life in people with chronic kidney disease: focusing on modifiable risk factors.
    Curr Opin Nephrol Hypertens. 2024 Jul 23. doi: 10.1097/MNH.0000000000001013.
    PubMed     Abstract available
    
    
    
38. DANZIGER J
    Synergistic susceptibility to environmental lead toxicity in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jul 18. doi: 10.1097/MNH.0000000000000991.
    PubMed     Abstract available
    
    
    June 2024
39. TUTTLE M, Sarnak MJ, Navaneethan SD
    Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jun 20. doi: 10.1097/MNH.0000000000001008.
    PubMed     Abstract available
    
    
    April 2024
40. EVENEPOEL P, Jorgensen HS
    Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Apr 24. doi: 10.1097/MNH.0000000000000992.
    PubMed     Abstract available
    
    
    
41. FAIVRE A, de Seigneux S
    The role of hypoxia in chronic kidney disease: a nuanced perspective.
    Curr Opin Nephrol Hypertens. 2024 Apr 11. doi: 10.1097/MNH.0000000000000989.
    PubMed     Abstract available
    
    
    
42. HUISH S, Sinha S
    New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Apr 5. doi: 10.1097/MNH.0000000000000985.
    PubMed     Abstract available
    
    
    March 2024
43. ALEXIUK M, Tangri N
    Prediction models for earlier stages of chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Mar 1. doi: 10.1097/MNH.0000000000000981.
    PubMed     Abstract available
    
    
    February 2024
44. HOLLIDAY MW JR, Frost L, Navaneethan SD
    Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression.
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000976.
    PubMed     Abstract available
    
    
    
45. HUNDEMER GL, Akbari A, Sood MM
    Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?
    Curr Opin Nephrol Hypertens. 2024 Feb 26. doi: 10.1097/MNH.0000000000000971.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Renal Failure is free of charge.